TransMedics Group, Inc. beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.50 | $0.44 | -12.0% | Miss |
| Q12026 FY2026 | $0.62 | $0.30 | -51.6% | Miss |
| Q42025 FY2025 | $0.41 | $0.57 | +39.0% | Beat |
Back to TMDX overview · TMDX holders · TMDX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.